Anti-Angiotensin II Type 2 Receptor antibody [EPR3876] (ab92445)

Publishing research using ab92445? Please let us know so that we can cite the reference in this datasheet.

ab92445 has been referenced in 3 publications.

  • Alhusban A  et al. Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis. J Pharmacol Exp Ther 350:635-45 (2014). PubMed: 24990940
  • Alhusban A  et al. AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J Pharmacol Exp Ther 344:348-59 (2013). Rat . PubMed: 23211364
  • Montez P  et al. Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats. Endocrinology 153:5746-59 (2012). Rat . PubMed: 23087176

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"